Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Could high plasma bikunin predict a favorable outcome in ovarian cancer?

Nature Clinical Practice Oncology volume 2, pages 502–503 (2005)Cite this article

boxed-textMatsuzaki et al. (2005) Plasma bikunin as a favorable prognostic factor in ovarian cancer. J Clin Oncol 23: 1463–1472

Following additional confirmation in independent studies, serum bikunin could have an important role in managing the treatment of women with newly diagnosed early-stage ovarian cancer

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Mano A et al. (2005) CA-125 AUC as a new prognostic factor for patients with ovarian cancer. Gynecol Oncol 97: 529–534

    Article  CAS  PubMed  Google Scholar 

  2. Bast RC Jr et al. (2002) Early detection of ovarian cancer: promise and reality. Cancer Treat Res 107: 61–97

    PubMed  Google Scholar 

  3. Hellstrom I et al. (2003) The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res 63: 3695–3700

    PubMed  Google Scholar 

  4. McIntosh MW et al. (2004) Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma. Gynecol Oncol 95: 9–15

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Shridhar V et al. (2001) Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res 61: 5895–5904

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Associate Member at the Fred Hutchinson Cancer Research Center and Principal Investigator of the Computational Proteomics Laboratory, Seattle, WA, USA

    Martin McIntosh

Authors
  1. Martin McIntosh
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McIntosh, M. Could high plasma bikunin predict a favorable outcome in ovarian cancer?. Nat Rev Clin Oncol 2, 502–503 (2005). https://doi.org/10.1038/ncponc0315

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0315

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing